1ST 206
Alternative Names: 1ST-206Latest Information Update: 03 Feb 2023
At a glance
- Originator 1St Biotherapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 05 Jan 2023 Early research in Cancer in South Korea (unspecified route) (1St Biotherapeutics pipeline, January 2023)